1984 graduated from the former clinical medicine department of Zhejiang Medical University, and has been engaged in tumor clinical and scientific research teaching for a long time. 1September 1987 and1September 19991September 1987 studied for master's and doctor's degrees in the former Institute of Oncology of Zhejiang Medical University, studied under the famous oncologist Professor Zheng Shu, engaged in the research of photodynamic therapy for malignant tumors and the experimental study of P53 gene in colorectal cancer, and participated in the national key project "Basic and Clinical Research of Colorectal Cancer" as a main member during the Seventh Five-Year Plan and the Eighth Five-Year Plan. 1997-2000 worked as a postdoctoral fellow in Cornell University Medical College/new york Hospital for three years, engaged in the research of gene diagnosis and experimental gene therapy of tumors, involving the expression of telomerase and experimental treatment of human tumors, and the expression of Cox2 in pancreatic tumors and thyroid tumors. After returning to China in 2000, he mainly worked in the management of scientific research and teaching and the basic and clinical research of tumor in Zhejiang First Hospital. Clinically, the chief surgeon has completed more than 1 1,000 major tumor operations, and has a deep understanding of the multidisciplinary comprehensive treatment of common malignant tumors. At present, he has presided over more than 10 sub-projects of "973", National Natural Fund and provincial and ministerial projects. In recent years, more than 20 high-level papers have been published, including 6 papers included in SCI. There is an independent research team and research goal in the hospital, and it is the first in the province to carry out experimental gene therapy research on tumors.
Related papers were published in high-level journals such as Cancer Research, J Clin Endocrine Metabolism and Surgery. After returning to China, he has been engaged in scientific and educational management and basic and clinical research of tumors in the First Hospital of Zhejiang Medical University. He is good at surgical treatment and multidisciplinary comprehensive treatment of common digestive system tumors such as gastric cancer and colon cancer, and actively advocates molecular targeted treatment and individualized treatment of malignant tumors. In postgraduate education, we should pay attention to cultivating independent scientific research and clinical thinking ability, quality education and teamwork spirit. In scientific research, its main research direction focuses on biological therapy (including molecular targeted therapy) and individualized therapy of tumors. Up to now, 5 doctoral students, 8 master students and 9 master students have been trained. He has presided over the completion of the national "973" project sub-projects, the national natural fund and the provincial natural fund youth team project (the provincial natural outstanding youth fund), presided over the completion of the "973" project sub-projects, the 863 major project sub-projects, the national natural fund and the provincial science and technology department major projects, and funded more than 3 million yuan. In recent years, he has published more than 30 high-level SCI papers, applied for 2 national invention patents and won the Zhejiang Medical and Health Award.